Inova Cardiogenic Shock Registry (INOVA SHOCK)
| Status: | Recruiting |
|---|---|
| Conditions: | Cardiology, Hospital |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Other |
| Healthy: | No |
| Age Range: | 18 - 85 |
| Updated: | 2/22/2019 |
| Start Date: | January 1, 2018 |
| End Date: | May 29, 2020 |
| Contact: | Stephanie Garofalo, BSN |
| Email: | Stephanie.Garofalo@inova.org |
| Phone: | 703-776-7702 |
Implementation of a Cardiogenic Shock Team and Clinical Outcomes (INOVA-SHOCK Registry)
To collect retrospective clinical outcomes related to acute decompensated heart failure
cardiogenic shock, acute myocardial infarction cardiogenic shock and compare current versus
historical survival rates.
To collect Inova Heart and Vascular Institute (IHVI) site specific outcomes before and after
initiation of the Cardiogenic Shock team on January 1, 2017.
To collect outcomes related to implementation of mechanical circulatory support versus no
circulatory intervention and type of intervention (extracorporeal membrane oxygenation (ECMO)
versus intracorporeal axial-flow (Impella).
• Assess survival at three time points.
cardiogenic shock, acute myocardial infarction cardiogenic shock and compare current versus
historical survival rates.
To collect Inova Heart and Vascular Institute (IHVI) site specific outcomes before and after
initiation of the Cardiogenic Shock team on January 1, 2017.
To collect outcomes related to implementation of mechanical circulatory support versus no
circulatory intervention and type of intervention (extracorporeal membrane oxygenation (ECMO)
versus intracorporeal axial-flow (Impella).
• Assess survival at three time points.
Any patient with cardiogenic shock, whether inpatient or transferred from another facility,
treated at the Inova Heart and Vascular Institute shall be included in this registry. This
includes adults with and without decision making capacity over the age of 18 years old.
The primary investigator (PI) will designate the data points to be included in the database
in order to assess the efficiency of procedures and protocols in the treatment of cardiogenic
shock at the IHVI as administered by the Shock team, to identify relationships between
treatment and negative morbidity and mortality outcomes, and to monitor and improve quality
of care delivered.
treated at the Inova Heart and Vascular Institute shall be included in this registry. This
includes adults with and without decision making capacity over the age of 18 years old.
The primary investigator (PI) will designate the data points to be included in the database
in order to assess the efficiency of procedures and protocols in the treatment of cardiogenic
shock at the IHVI as administered by the Shock team, to identify relationships between
treatment and negative morbidity and mortality outcomes, and to monitor and improve quality
of care delivered.
Inclusion Criteria:
-Patients at the IHVI with documented Cardiogenic Shock team intervention for acute
decompensated heart failure cardiogenic shock, or acute myocardial infarction cardiogenic
shock.
Exclusion Criteria:
-Patients under the age of 18 will be excluded.
We found this trial at
1
site
3300 Gallows Road
Falls Church, Virginia 22042
Falls Church, Virginia 22042
(703) 776-4001
Principal Investigator: Alex Truesdell, MD
Phone: 703-786-5987
Inova Fairfax Hospital Inova Fairfax Hospital, Inova's flagship hospital, is an 833-bed, nationally recognized regional...
Click here to add this to my saved trials
